NCT05857124View on ClinicalTrials.gov

A Study Evaluating the Efficacy of the Vielight Neuro RX Gamma in the Treatment of Post COVID-19 Cognitive Impairment

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

September 1, 2024

Study Completion Date

January 16, 2025

Conditions
Post COVID-19 Cognitive Impairment
Interventions
DEVICE

Vielight Neuro RX Gamma active device

The Vielight Neuro RX Gamma active device is a home-use photobiomodulation (PBM) device designed to deliver near-infrared (810 nm) light (or photons) to the brain/scalp and nasal tissues.

DEVICE

Vielight Neuro RX Gamma sham device

The Vielight Neuro RX Gamma sham device is a home-use device similar to the Vielight Neuro RX Gamma active device, but acting as a sham.

Trial Locations (1)

92835

Ascada Research, Fullerton

All Listed Sponsors
lead

Vielight Inc.

INDUSTRY